Interaksi Parasetamol dan kodein dan Nalmefen

Parasetamol dan kodein dan Nalmefen: kedua label peresepan menandai kombinasi ini dengan bahasa yang paling tegas, seperti kontraindikasi, peringatan kotak hitam, atau instruksi untuk menghindarinya.

Mayor

Jangan dikombinasikan tanpa arahan dokter yang meresepkan. Bahasa label di bawah ini adalah yang paling tegas yang digunakan FDA.

Apa kata label FDA

Dari label Parasetamol dan kodein (ACETAMINOPHEN AND CODEINE PHOSPHATE) · berlaku sejak 2026-01-22

Mayor

Consider recommending or prescribing an opioid overdose reversal agent ( see WARNINGS, Life-Threatening Respiratory Depression ; DOSAGE AND ADMINISTRATION, Patient Access to Naloxone for the Emergency Treatment of Opioid Overdose ).

Peringatanberdasarkan golongan obatLihat label di DailyMed
Mayor

If concomitant use is warranted, consider recommending or prescribing an opioid overdose reversal agent ( see WARNINGS, Life-Threatening Respiratory Depression ; DOSAGE AND ADMINISTRATION , Patient Access to Naloxone for the Emergency Treatment of Opioid Overdose ).

Peringatanberdasarkan golongan obatLihat label di DailyMed
Moderat

Patient Access to an Opioid Overdose Reversal Agent for the Emergency Treatment of Opioid Overdose Inform patients and caregivers about opioid overdose reversal agents (e.g., naloxone, nalmefene).

Peringatanmenyebut NalmefenLihat label di DailyMed
Moderat

Explain to patients and caregivers that effects of opioid overdose reversal agents like naloxone and nalmefene are temporary, and that they must call 911 or get emergency medical help right away in all cases of known or suspected opioid overdose, even if an opioid overdose reversal agent is administered ( see OVERDOSAGE ) .

Perhatianmenyebut NalmefenLihat label di DailyMed

Dari label Nalmefen (Zurnai) · berlaku sejak 2026-07-31

Mayor

Risk of Recurrent Respiratory and CNS Depression : A recurrence of respiratory depression is possible, therefore, keep the patient under continued surveillance and administer repeat doses of ZURNAI using a new auto-injector with each dose while awaiting emergency medical assistance.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Mayor

In neonates, opioid withdrawal may be life-threatening if not recognized and properly treated.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Mayor

While the duration of action of nalmefene is as long as most opioids, a recurrence of respiratory depression is possible, even after an apparently adequate initial response to ZURNAI treatment [see Clinical Pharmacology (12.3) ].

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Mayor

In neonates, opioid withdrawal may be life-threatening if not recognized and properly treated and may include the following signs and symptoms: convulsions, excessive crying, and hyperactive reflexes.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Mayor

There may be clinical settings, particularly the postpartum period in neonates with known or suspected exposure to maternal opioid use, where it is preferable to avoid the abrupt precipitation of opioid withdrawal symptoms.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed

Menggunakan lebih dari dua obat ini? Interaksi saling bertumpuk. Periksa seluruh daftar Anda sekaligus; daftar itu tetap berada di peramban Anda.

Buka di pemeriksa

Bukan nasihat medis. Interaction Checker mengutip teks label FDA dan lembar fakta NIH. Penting atau tidaknya suatu interaksi bagi Anda bergantung pada dosis, waktu penggunaan, fungsi ginjal dan hati, serta kondisi lain. Pastikan dengan apoteker atau dokter yang meresepkan.